Filing Flows › Orthofix Medical (OFIX) › R&D spending
Orthofix Medical (OFIX) R&D spending by quarter
Orthofix Medical's R&D spending was $15.9M in Q2 FY26 (second quarter fiscal 2026), +4% from Q1 FY26. Over the last 7 quarters it ranged from $14.8M (Q3 FY25) to $19.8M (Q1 FY25).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 FY26 | $15.9M | +4% | +0.1% |
| Q1 FY26 | $15.3M | -0.3% | -22% |
| Q4 FY25 | $15.4M | +4% | -18% |
| Q3 FY25 | $14.8M | -7% | — |
| Q2 FY25 | $15.9M | -19% | — |
| Q1 FY25 | $19.8M | +5% | — |
| Q4 FY24 | $18.8M | — | — |
Q2 FY26 at a glance
Orthofix Medical, Q2 FY26: revenue $211M (+4% year over year), operating margin -3.9%, net loss $15.8M, operating cash flow −$6.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is Orthofix Medical's R&D spending?
Orthofix Medical's R&D spending was $15.9M in Q2 FY26 (second quarter fiscal 2026), +4% from Q1 FY26.
How has Orthofix Medical's R&D spending changed?
Over the last 7 quarters it ranged from $14.8M (Q3 FY25) to $19.8M (Q1 FY25).